An economic evaluation of oral compared with intravenous ganciclovir for maintenance treatment of newly diagnosed for maintenance treatment of newly diagnosed cytomegalovirus retinitis in AIDS patients
Authors:
- Stephen E. FollansbeeSFStephen E. Follansbee
- 1 May 1996
- journal article
- clinical trial
- Published by Elsevier in Clinical Therapeutics
- Vol. 18 (3) , 546-558
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Oral Ganciclovir as Maintenance Treatment for Cytomegalovirus Retinitis in Patients with AIDSNew England Journal of Medicine, 1995
- Foscarnet—Ganciclovir Cytomegalovwus Retinitis TrialOphthalmology, 1994
- Clinical Manifestations of AIDS in the Era of Pneumocystis ProphylaxisNew England Journal of Medicine, 1993
- Incidence and Natural History of Cytomegalovirus Disease in Patients with Advanced Human Immunodeficiency Virus Disease Treated with ZidovudineThe Journal of Infectious Diseases, 1992
- Progression Rates of Cytomegalovirus Retinopathy in Ganciclovir-Treated and Untreated PatientsArchives of Ophthalmology (1950), 1992
- Economic Analysis Alongside Clinical Trials: Revisiting the Methodological IssuesInternational Journal of Technology Assessment in Health Care, 1991
- Cytomegalovirus Retinitis and Acquired Immunodeficiency SyndromeArchives of Ophthalmology (1950), 1989
- The Diagnosis of Cytomegalovirus RetinitisAnnals of Internal Medicine, 1988
- Cytomegalovirus Infection in Patients with AIDSThe Journal of Infectious Diseases, 1988
- Ganciclovir Treatment of Life- or Sight-Threatening Cytomegalovirus Infection: Experience in 314 Immunocompromised PatientsClinical Infectious Diseases, 1988